Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short term Debt (2016 - 2020)

Fortress Biotech (FBIO) has 5 years of Short term Debt data on record, last reported at $413000.0 in Q2 2020.

  • For Q2 2020, Short term Debt changed N/A year-over-year to $413000.0; the TTM value through Jun 2020 reached $413000.0, changed N/A, while the annual FY2019 figure was $27000.0, 97.28% down from the prior year.
  • Short term Debt reached $413000.0 in Q2 2020 per FBIO's latest filing, up from $69000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $991000.0 in Q4 2018 and bottomed at $16000.0 in Q1 2019.
  • Average Short term Debt over 5 years is $305615.4, with a median of $203000.0 recorded in 2016.
  • Peak YoY movement for Short term Debt: plummeted 97.28% in 2019, then skyrocketed 331.25% in 2020.
  • A 5-year view of Short term Debt shows it stood at $951000.0 in 2016, then crashed by 67.51% to $309000.0 in 2017, then surged by 220.71% to $991000.0 in 2018, then tumbled by 97.28% to $27000.0 in 2019, then surged by 1429.63% to $413000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $413000.0 in Q2 2020, $69000.0 in Q1 2020, and $27000.0 in Q4 2019.